Chart Check: This pharma stock hits fresh 52-week high in December; likely to scale Rs 24,000
For more than a decade, the stock has been taking support at a rising moving average followed by a breach of the intermediate falling trendline. In recent context, the stock is rising with the same characteristic,” he said.
